Smart Drug Shrinks Tumours by 30% in Early Cancer Trials

An experimental tablet has shown promising results in early trials, shrinking tumours by at least 30% in six common cancer types. The drug works by preventing cancer cells from evading treatment, addressing a significant challenge in immunotherapy. Patients express renewed hope following these encouraging findings.

Read the full story at The Guardian AU→